135 related articles for article (PubMed ID: 31177399)
21. Nitroglycerin Enhances Cisplatin-Induced Cytotoxicity via AKT Inactivation and Thymidylate Synthase Downregulation in Human Lung Cancer Cells.
Ko JC; Chen JC; Yen TC; Chen TY; Ma PF; Lin YC; Cheng HH; Taso YC; Lin YW
Pharmacology; 2020; 105(3-4):209-224. PubMed ID: 31630149
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231.
Garbar C; Mascaux C; Giustiniani J; Merrouche Y; Bensussan A
Sci Rep; 2017 Aug; 7(1):7201. PubMed ID: 28775276
[TBL] [Abstract][Full Text] [Related]
23. Bisdemethoxycurcumin sensitizes cisplatin-resistant lung cancer cells to chemotherapy by inhibition of CA916798 and PI3K/AKT signaling.
Wang HJ; Yang ZX; Dai XT; Chen YF; Yang HP; Zhou XD
Apoptosis; 2017 Sep; 22(9):1157-1168. PubMed ID: 28677094
[TBL] [Abstract][Full Text] [Related]
24. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
25. MEDI3039, a novel highly potent tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 2 agonist, causes regression of orthotopic tumors and inhibits outgrowth of metastatic triple-negative breast cancer.
Greer YE; Gilbert SF; Gril B; Narwal R; Peacock Brooks DL; Tice DA; Steeg PS; Lipkowitz S
Breast Cancer Res; 2019 Feb; 21(1):27. PubMed ID: 30777098
[TBL] [Abstract][Full Text] [Related]
26. Accumulation and photodynamic activity of chlorin e6 in cisplatin-resistant human lung cancer cells.
Horibe S; Nagai J; Yumoto R; Tawa R; Takano M
J Pharm Sci; 2011 Jul; 100(7):3010-7. PubMed ID: 21274848
[TBL] [Abstract][Full Text] [Related]
27. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway.
Yu M; Qi B; Xiaoxiang W; Xu J; Liu X
Biomed Pharmacother; 2017 Jun; 90():677-685. PubMed ID: 28415048
[TBL] [Abstract][Full Text] [Related]
28. Salinomycin reduces growth, proliferation and metastasis of cisplatin resistant breast cancer cells via NF-kB deregulation.
Tyagi M; Patro BS
Toxicol In Vitro; 2019 Oct; 60():125-133. PubMed ID: 31077746
[TBL] [Abstract][Full Text] [Related]
29. HtrA1 downregulation induces cisplatin resistance in lung adenocarcinoma by promoting cancer stem cell-like properties.
Xu Y; Jiang Z; Zhang Z; Sun N; Zhang M; Xie J; Li T; Hou Y; Wu D
J Cell Biochem; 2014 Jun; 115(6):1112-21. PubMed ID: 24356998
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of p90RSK activation sensitizes triple-negative breast cancer cells to cisplatin by inhibiting proliferation, migration and EMT.
Jin Y; Huynh DTN; Kang KW; Myung CS; Heo KS
BMB Rep; 2019 Dec; 52(12):706-711. PubMed ID: 31818359
[TBL] [Abstract][Full Text] [Related]
31. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
[TBL] [Abstract][Full Text] [Related]
32. Ginsenoside Rh2 Improves the Cisplatin Anti-tumor Effect in Lung Adenocarcinoma A549 Cells via Superoxide and PD-L1.
Chen Y; Zhang Y; Song W; Zhang Y; Dong X; Tan M
Anticancer Agents Med Chem; 2020; 20(4):495-503. PubMed ID: 31814556
[TBL] [Abstract][Full Text] [Related]
33. [Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells].
Zhang MC; Hu CP; Chen Q
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):408-12. PubMed ID: 17152483
[TBL] [Abstract][Full Text] [Related]
34. Carbon ion beam combined with cisplatin effectively disrupts triple negative breast cancer stem-like cells in vitro.
Sai S; Vares G; Kim EH; Karasawa K; Wang B; Nenoi M; Horimoto Y; Hayashi M
Mol Cancer; 2015 Sep; 14():166. PubMed ID: 26338199
[TBL] [Abstract][Full Text] [Related]
35. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
ter Haar E; Day BW
Anticancer Res; 1996; 16(3A):1107-15. PubMed ID: 8702221
[TBL] [Abstract][Full Text] [Related]
36. Anti-tumor activity of novel biisoquinoline derivatives against breast cancers.
Jaiswal AS; Hirsch-Weil D; Proulx ER; Hong S; Narayan S
Bioorg Med Chem Lett; 2014 Oct; 24(20):4850-3. PubMed ID: 25240616
[TBL] [Abstract][Full Text] [Related]
37. Cytotoxic pathways activated by multifunctional thiosemicarbazones targeting sigma-2 receptors in breast and lung carcinoma cells.
Kopecka J; Barbanente A; Vitone D; Arnesano F; Margiotta N; Berchialla P; Niso M; Riganti C; Abate C
Pharmacol Rep; 2023 Dec; 75(6):1588-1596. PubMed ID: 37796435
[TBL] [Abstract][Full Text] [Related]
38. ER stress and autophagy are involved in the apoptosis induced by cisplatin in human lung cancer cells.
Shi S; Tan P; Yan B; Gao R; Zhao J; Wang J; Guo J; Li N; Ma Z
Oncol Rep; 2016 May; 35(5):2606-14. PubMed ID: 26985651
[TBL] [Abstract][Full Text] [Related]
39. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
40. NEAT1 contributes to the CSC-like traits of A549/CDDP cells via activating Wnt signaling pathway.
Jiang P; Xu H; Xu C; Chen A; Chen L; Zhou M; Haq IU; Wu X; Mariyam Z; Feng Q
Chem Biol Interact; 2018 Dec; 296():154-161. PubMed ID: 30291867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
